Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of gemcitabine and docetaxel for patients with recurrent stage III or stage IV non-small cell lung cancer ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Taxotere (docetaxel)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED